期刊文献+

HPV亚型与宫颈上皮内瘤变Ⅰ转归的关系 被引量:1

Relationship of cervical HPV infection and outcomes of cervical intraepithelial neoplasia Ⅰ
原文传递
导出
摘要 目的探讨HPV亚型与宫颈上皮内瘤变Ⅰ(CINⅠ)患者转归的关系。方法病理学确诊为CINⅠ患者886例,对其进行HPV-DNA分型测定。于确诊后4、8个月及1、2、3年随访CINⅠ转归情况。结果 886例中,自然好转或持续不变806例(≤CINⅠ),病理升级为CINⅡ/Ⅲ甚至宫颈浸润癌80例(≥CINⅡ)。HPV阳性481例:HPV16阳性59例,3年病理升级10例(16.95%);HPV52阳性53例,3年病理升级8例(15.09%);HPV53阳性62例,3年病理升级12例(19.35%);HPV68阳性25例,3年病理升级4例(16.00%)。HPV16、HPV52、HPV53和HPV68阳性患者3年累计病理升级率高于HPV阴性患者(P<0.05)。结论 HPV53、HPV16、HPV68和HPV52阳性的CINⅠ患者,病理升级风险较高。 Objective To investigate the relationship of human papillomavirus(HPV)genotype and pathological upgrades of the patients with cervical intraepithelial neoplasia Ⅰ(CIN Ⅰ).Methods The HPV-DNA typing was performed in 886 patients with CIN Ⅰ and the outcomes of the CIN Ⅰwere followed up in the 4^th and 8^th month and 1^st,2^nd and 3^rd year,respectively.Results Of 886 cases,806 cases were spontaneously improved or unchanged(≤CIN Ⅰ),80 cases were upgraded to CIN Ⅱ-Ⅲ or invasive cervical cancer(≥CIN Ⅱ).Of 481 cases with HPV positive,59 cases were HPV16 positive with pathologically 3-year upgrading rate of 16.95%(10/59),53 cases were HPV52 positive with pathologically 3-year upgrading rate of 15.09%(8/53),62 cases were HPV53 positive with pathologically 3-year upgrading rate of 19.35%(12/62),and 25 cases were HPV68 positive with pathologically 3-year upgrading rate of 16.00%(4/25).The pathologically 3-year upgrading cumulative rate of HPV positives was significantly higher than that of HPV negatives(P〈0.05).Conclusions The CIN Ⅰ patients with HPV53,HPV16,HPV68 and HPV52 positive have a higher risk for histopathological upgrading.
作者 苏莉 于澎静 夏林 SU Li;YU Pengjing;XIA Lin(Derpartment of Gynecology and Obstetrics, People's Hospital of Yangzhong, Yangzhong 212200, CHINA)
出处 《江苏医药》 CAS 2018年第6期668-670,共3页 Jiangsu Medical Journal
基金 镇江市社会发展指导性项目(FZ2015058)
关键词 宫颈上皮内瘤变 人类乳头状病毒 Cervical intraepithelial neoplasia Human papillomavirus
  • 相关文献

参考文献4

二级参考文献21

  • 1汤惠茹,魏丽惠,吴瑞芳,周艳秋.不同程度宫颈病变感染人乳头瘤病毒的优势亚型[J].华中科技大学学报(医学版),2006,35(6):771-773. 被引量:9
  • 2陈庆云,卞美璐,陈志华,刘军.宫颈癌癌前病变中人乳头状瘤病毒16整合状态的检测[J].中华医学杂志,2005,85(6):400-404. 被引量:13
  • 3李晓红,董卫红,黄在菊,张惠芳,王泽华.子宫颈癌前病变组织DNA倍体分析与人乳头状瘤病毒亚型检测[J].中华妇产科杂志,2006,41(3):205-206. 被引量:19
  • 4洪慧丽,涂知明.TCT查验子宫颈涂片中HPV感染的研究[J].中国优生与遗传杂志,2006,14(9):79-80. 被引量:8
  • 5李旻,曹箭,王乃鹏,李龙玉,李凌,乔友林,潘秦镜.p16^(INK4a)免疫细胞化学检测在筛查宫颈癌中的作用[J].中华肿瘤杂志,2006,28(9):674-677. 被引量:9
  • 6J. Thomas Cox,Phillip E. Castle,Catherine M. Behrens,Abha Sharma,Thomas C. Wright,Jack Cuzick.Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study[J]. American Journal of Obstetrics and Gynecology . 2012
  • 7Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study[J]. Lancet Oncology . 2010 (11)
  • 8Yuli Chang,Noel T. Brewer,Allen C. Rinas,Karla Schmitt,Jennifer S. Smith.Evaluating the impact of human papillomavirus vaccines[J]. Vaccine . 2009 (32)
  • 9Debbie Saslow,Diane Solomon,Herschel W. Lawson.American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. AMERICAN JOURNAL OF CLINICAL PATHOLOGY . 2012
  • 10Pierry Deirdre,Weiss Gerald,Lack Benjamin,Chen Victor,Fusco Judy.Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age. Archives of Pathology . 2012

共引文献47

同被引文献11

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部